a developer of allogeneic chimeric antigen receptor therapy
Industry Biotechnology
A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.
Ticker / NAME | Correlation To ALLO | 1D Price Change % | ||
---|---|---|---|---|
ALLO | 100% | -9.56% | ||
FATE - ALLO | 59% Loosely correlated | -4.15% | ||
NTLA - ALLO | 56% Loosely correlated | -6.15% | ||
CRSP - ALLO | 55% Loosely correlated | -5.90% | ||
CRBU - ALLO | 54% Loosely correlated | -5.00% | ||
BEAM - ALLO | 53% Loosely correlated | -4.33% | ||
More |
Ticker / NAME | Correlation To ALLO | 1D Price Change % |
---|---|---|
ALLO | 100% | -9.56% |
drugs theme (254 stocks) | 51% Loosely correlated | -1.67% |
therapy theme (23 stocks) | 46% Loosely correlated | -3.44% |
biotechnology theme (238 stocks) | 25% Poorly correlated | -1.76% |